Abstract
Pancreatic islets are the body’s central rheostat that regulates glucose homeostasis through the production of different hormones, including β cell-derived insulin. During obesity-induced type 2 diabetes (T2D), islet β cells become dysfunctional and inadequate insulin secretion no longer ensures glycemic control. T2D is associated with a chronic low-grade inflammation that manifests in several metabolic organs including the pancreatic islets. Growing evidence suggests that components of the innate immune system, and especially macrophages, play a crucial role in regulating islet homeostasis. Yet, the phenotypes and functions of islet macrophages in physiology and during T2D have only started to attract attention and remain unclear. In this review, the current knowledge about islet inflammation and macrophages will be summarized in humans and rodent models. Recent findings on the cellular and molecular mechanisms involved in islet remodeling and β cell function during obesity and T2D will be discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Aguayo-Mazzucato C, Bonner-Weir S (2018) Pancreatic beta cell regeneration as a possible therapy for diabetes. Cell Metab 27:57–67
Agudo J et al (2012) Vascular endothelial growth factor-mediated islet hypervascularization and inflammation contribute to progressive reduction of beta-cell mass. Diabetes 61:2851–2861
Ahlqvist E, Prasad RB, Groop L (2020) Subtypes of type 2 diabetes determined from clinical parameters. Diabetes 69:2086–2093
Avrahami D et al (2020) Single-cell transcriptomics of human islet ontogeny defines the molecular basis of beta-cell dedifferentiation in T2D. Mol Metab 42:101057
Banaei-Bouchareb L et al (2004) Insulin cell mass is altered in Csf1op/Csf1op macrophage-deficient mice. J Leukoc Biol 76:359–367
Blencowe M et al (2021) IAPP-induced beta cell stress recapitulates the islet transcriptome in type 2 diabetes. Diabetologia 65:173–187
Boni-Schnetzler M et al (2008) Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation. J Clin Endocrinol Metab 93:4065–4074
Boni-Schnetzler M et al (2009) Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I. Endocrinology 150:5218–5229
Boni-Schnetzler M et al (2018) Beta cell-specific deletion of the IL-1 receptor antagonist impairs beta cell proliferation and insulin secretion. Cell Rep 22:1774–1786
Boni-Schnetzler M et al (2021) IL-1beta promotes the age-associated decline of beta cell function. iScience 24:103250
Burke SJ et al (2018) Pancreatic deletion of the interleukin-1 receptor disrupts whole body glucose homeostasis and promotes islet beta-cell de-differentiation. Mol Metab 14:95–107
Butcher MJ et al (2014) Association of proinflammatory cytokines and islet resident leucocytes with islet dysfunction in type 2 diabetes. Diabetologia 57:491–501
Butler AE et al (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102–110
Calderon B et al (2015) The pancreas anatomy conditions the origin and properties of resident macrophages. J Exp Med 212:1497–1512
Carrero JA et al (2017) Resident macrophages of pancreatic islets have a seminal role in the initiation of autoimmune diabetes of NOD mice. Proc Natl Acad Sci U S A 114:E10418–E10427
Chan JY et al (2013) Failure of the adaptive unfolded protein response in islets of obese mice is linked with abnormalities in beta-cell gene expression and progression to diabetes. Diabetes 62:1557–1568
Chan JY et al (2019) Macrophage alterations in islets of obese mice linked to beta cell disruption in diabetes. Diabetologia 62:993–999
Chittezhath M et al (2019) Islet macrophages are associated with islet vascular remodeling and compensatory hyperinsulinemia during diabetes. Am J Physiol Endocrinol Metab 317:E1108–E1120
Cohrs CM et al (2020) Dysfunction of persisting beta cells is a key feature of early type 2 diabetes pathogenesis. Cell Rep 31:107469
Cucak H, Grunnet LG, Rosendahl A (2014) Accumulation of M1-like macrophages in type 2 diabetic islets is followed by a systemic shift in macrophage polarization. J Leukoc Biol 95:149–160
Dalmas E et al (2017) Interleukin-33-activated islet-resident innate lymphoid cells promote insulin secretion through myeloid cell retinoic acid production. Immunity 47:928–942 e7
Denroche HC et al (2021) T cells accumulate in non-diabetic islets during ageing. Immun Ageing 18:8
Dominguez-Gutierrez G, Xin Y, Gromada J (2019) Heterogeneity of human pancreatic beta-cells. Mol Metab 27S:S7–S14
Donath MY, Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11:98–107
Donath MY, Dinarello CA, Mandrup-Poulsen T (2019) Targeting innate immune mediators in type 1 and type 2 diabetes. Nat Rev Immunol 19:734–746
Dror E et al (2017) Postprandial macrophage-derived IL-1beta stimulates insulin, and both synergistically promote glucose disposal and inflammation. Nat Immunol 18:283–292
Ebrahimi AG et al (2020) Beta cell identity changes with mild hyperglycemia: implications for function, growth, and vulnerability. Mol Metab. 35:100959
Eguchi K et al (2012) Saturated fatty acid and TLR signaling link beta cell dysfunction and islet inflammation. Cell Metab 15:518–533
Ehses JA et al (2007) Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 56:2356–2370
Eizirik DL, Korbutt GS, Hellerstrom C (1992) Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the beta-cell function. J Clin Invest 90:1263–1268
Ferris ST et al (2017) The islet-resident macrophage is in an inflammatory state and senses microbial products in blood. J Exp Med 214:2369–2385
Furman D et al (2019) Chronic inflammation in the etiology of disease across the life span. Nat Med 25:1822–1832
Gerst F et al (2017) Metabolic crosstalk between fatty pancreas and fatty liver: effects on local inflammation and insulin secretion. Diabetologia 60:2240–2251
Gerst F et al (2019) What role do fat cells play in pancreatic tissue? Mol Metab 25:1–10
Gregor MF, Hotamisligil GS (2011) Inflammatory mechanisms in obesity. Annu Rev Immunol 29:415–445
Guilliams M et al (2020) Establishment and maintenance of the macrophage niche. Immunity 52:434–451
Hajmrle C et al (2016) Interleukin-1 signaling contributes to acute islet compensation. JCI Insight 1:e86055
Hasnain SZ et al (2014) Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress. Nat Med 20:1417–1426
He W, Yuan T, Maedler K (2019) Macrophage-associated pro-inflammatory state in human islets from obese individuals. Nutr Diabetes 9:36
Herder C et al (2021) Differences in biomarkers of inflammation between novel subgroups of recent-onset diabetes. Diabetes 70:1198–1208
Homo-Delarche F et al (2006) Islet inflammation and fibrosis in a spontaneous model of type 2 diabetes, the GK rat. Diabetes 55:1625–1633
Horii T et al (2020) Islet inflammation is associated with pancreatic fatty infiltration and hyperglycemia in type 2 diabetes. BMJ Open Diabetes Res Care 8
Hume DA et al (1984) The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80: macrophages of endocrine organs. Proc Natl Acad Sci U S A 81:4174–4177
Hunter CS, Stein RW (2017) Evidence for loss in identity, de-differentiation, and trans-differentiation of islet beta-cells in type 2 diabetes. Front Genet 8:35
Igoillo-Esteve M et al (2010) Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes. Diabetologia 53:1395–1405
Janjuha S et al (2018) Age-related islet inflammation marks the proliferative decline of pancreatic beta-cells in zebrafish. Elife 7
Ji J et al (2019a) Type 2 diabetes is associated with suppression of autophagy and lipid accumulation in beta-cells. J Cell Mol Med 23:2890–2900
Ji Y et al (2019b) Toll-like receptors TLR2 and TLR4 block the replication of pancreatic beta cells in diet-induced obesity. Nat Immunol 20:677–686
Jourdan T et al (2013) Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes. Nat Med 19:1132–1140
Kahn BB (1998) Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance. Cell 92:593–596
Kamata K et al (2014) Islet amyloid with macrophage migration correlates with augmented beta-cell deficits in type 2 diabetic patients. Amyloid 21:191–201
Kammoun HL et al (2018) Evidence against a role for NLRP3-driven islet inflammation in db/db mice. Mol Metab 10:66–73
Kanatsuka A, Kou S, Makino H (2018) IAPP/amylin and beta-cell failure: implication of the risk factors of type 2 diabetes. Diabetol Int 9:143–157
Kleinert M et al (2018) Animal models of obesity and diabetes mellitus. Nat Rev Endocrinol 14:140–162
Lawlor N et al (2017) Single-cell transcriptomes identify human islet cell signatures and reveal cell-type-specific expression changes in type 2 diabetes. Genome Res 27:208–222
Lee Y et al (1994) Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc Natl Acad Sci U S A 91:10878–10882
Li N et al (2019) Aging and stress induced beta cell senescence and its implication in diabetes development. Aging (Albany NY) 11:9947–9959
Lu TT et al (2018) The polycomb-dependent epigenome controls beta cell dysfunction, dedifferentiation, and diabetes. Cell Metab 27:1294–1308 e7
Lundberg M et al (2017) Insulitis in human diabetes: a histological evaluation of donor pancreases. Diabetologia 60:346–353
Maedler K et al (2002) Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110:851–860
Mahdi T et al (2012) Secreted frizzled-related protein 4 reduces insulin secretion and is overexpressed in type 2 diabetes. Cell Metab 16:625–633
Marcelin G, Gautier EL, Clement K (2021) Adipose tissue fibrosis in obesity: etiology and challenges. Annu Rev Physiol
Marroqui L et al (2015) Pancreatic alpha cells are resistant to metabolic stress-induced apoptosis in type 2 diabetes. EBioMedicine 2:378–385
Marselli L et al (2020) Persistent or transient human beta cell dysfunction induced by metabolic stress: specific signatures and shared gene expression with type 2 diabetes. Cell Rep 33:108466
Martinez FO, Gordon S (2014) The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep 6:13
Martino L et al (2015) Mast cells infiltrate pancreatic islets in human type 1 diabetes. Diabetologia 58:2554–2562
Masters SL et al (2010) Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes. Nat Immunol 11:897–904
Meier JJ, Bonadonna RC (2013) Role of reduced beta-cell mass versus impaired beta-cell function in the pathogenesis of type 2 diabetes. Diabetes Care 36(Suppl 2):S113–S119
Meier DT et al (2014) Islet amyloid formation is an important determinant for inducing islet inflammation in high-fat-fed human IAPP transgenic mice. Diabetologia 57:1884–1888
Mezza T et al (2019) Beta-cell fate in human insulin resistance and type 2 diabetes: a perspective on islet plasticity. Diabetes 68:1121–1129
Nackiewicz D et al (2014) TLR2/6 and TLR4-activated macrophages contribute to islet inflammation and impair beta cell insulin gene expression via IL-1 and IL-6. Diabetologia 57:1645–1654
Nordmann TM et al (2017) The role of inflammation in beta-cell dedifferentiation. Sci Rep 7:6285
Prasad RB, Groop L (2015) Genetics of type 2 diabetes-pitfalls and possibilities. Genes (Basel) 6:87–123
Radenkovic M et al (2017) Characterization of resident lymphocytes in human pancreatic islets. Clin Exp Immunol 187:418–427
Richardson SJ et al (2009) Islet-associated macrophages in type 2 diabetes. Diabetologia 52:1686–1688
Rodriguez-Calvo T et al (2014) Increased immune cell infiltration of the exocrine pancreas: a possible contribution to the pathogenesis of type 1 diabetes. Diabetes 63:3880–3890
Rui J et al (2017) Beta cells that resist immunological attack develop during progression of autoimmune diabetes in NOD mice. Cell Metab 25:727–738
Saeedi P et al (2020) Mortality attributable to diabetes in 20-79 years old adults, 2019 estimates: results from the international diabetes federation diabetes atlas, 9(th) edition. Diabetes Res Clin Pract 162:108086
Sasaki H et al (2021) Reduced beta cell number rather than size is a major contributor to beta cell loss in type 2 diabetes. Diabetologia 64:1816–1821
Segerstolpe A et al (2016) Single-cell transcriptome profiling of human pancreatic islets in health and type 2 diabetes. Cell Metab 24:593–607
Sirdah MM, Reading NS (2020) Genetic predisposition in type 2 diabetes: a promising approach toward a personalized management of diabetes. Clin Genet 98:525–547
Solimena M et al (2018) Systems biology of the IMIDIA biobank from organ donors and pancreatectomised patients defines a novel transcriptomic signature of islets from individuals with type 2 diabetes. Diabetologia 61:641–657
Stancill JS et al (2021) Single-cell RNA sequencing of mouse islets exposed to proinflammatory cytokines. Life Sci Alliance 4
Taneera J et al (2012) A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets. Cell Metab 16:122–134
Tesi M et al (2021) Pro-inflammatory cytokines induce insulin and glucagon double positive human islet cells that are resistant to apoptosis. Biomol Ther 11
Tong X, Stein R (2021) Lipid droplets protect human beta cells from lipotoxic-induced stress and cell identity changes. Diabetes 70(11):2595–2607
Tong X et al (2020) Lipid droplet accumulation in human pancreatic islets is dependent on both donor age and health. Diabetes 69:342–354
Tushuizen ME et al (2007) Pancreatic fat content and beta-cell function in men with and without type 2 diabetes. Diabetes Care 30:2916–2921
Wan X et al (2018) Pancreatic islets communicate with lymphoid tissues via exocytosis of insulin peptides. Nature 560:107–111
Wang YJ et al (2016) Single-cell transcriptomics of the human endocrine pancreas. Diabetes 65:3028–3038
Weaver JR et al (2021) An increase in inflammation and islet dysfunction is a feature of prediabetes. Diabetes Metab Res Rev 37:e3405
Weir GC (2020) Glucolipotoxicity, beta-cells, and diabetes: the emperor has no clothes. Diabetes 69:273–278
Weitz JR et al (2020) Secretory functions of macrophages in the human pancreatic islet are regulated by endogenous purinergic signaling. Diabetes 69:1206–1218
Wen H et al (2011) Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol 12:408–415
Westwell-Roper C et al (2011) IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction. J Immunol 187:2755–2765
Wigger L et al (2021) Multi-omics profiling of living human pancreatic islet donors reveals heterogeneous beta cell trajectories towards type 2 diabetes. Nat Metab 3:1017–1031
Wu M et al (2021) Single-cell analysis of the human pancreas in type 2 diabetes using multi-spectral imaging mass cytometry. Cell Rep 37:109919
Xin Y et al (2016) RNA sequencing of single human islet cells reveals type 2 diabetes genes. Cell Metab 24:608–615
Ying W et al (2019) Expansion of islet-resident macrophages leads to inflammation affecting beta cell proliferation and function in obesity. Cell Metab 29:457–474 e5
Acknowledgements
This work was supported by the ATIP-Avenir and Emergence (Ville de Paris) Programmes and the EFSD/Novo Nordisk Programme for Diabetes Research in Europe to ED.
Conflict of Interest Statement
Nothing to declare.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Cuenco, J., Dalmas, E. (2022). Islet Inflammation and β Cell Dysfunction in Type 2 Diabetes. In: Eckel, J., Clément, K. (eds) From Obesity to Diabetes. Handbook of Experimental Pharmacology, vol 274. Springer, Cham. https://doi.org/10.1007/164_2021_571
Download citation
DOI: https://doi.org/10.1007/164_2021_571
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-99994-0
Online ISBN: 978-3-030-99995-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)